# a Polyphenol Whole Tumor Cell Vaccine in Patients With Advanced Malignant Solid Tumors

> **NCT06878612** · PHASE1 · RECRUITING · sponsor: **Xingchen Peng** · enrollment: 9 (estimated)

## Conditions studied

- Polyphenols
- Cancer Vaccine
- Advanced Solid Tumor

## Interventions

- **BIOLOGICAL:** Polyphenol whole tumor cell vaccine

## Key facts

- **NCT ID:** NCT06878612
- **Lead sponsor:** Xingchen Peng
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-21
- **Primary completion:** 2026-08-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 9 (ESTIMATED)
- **Last updated:** 2025-06-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06878612

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06878612, "a Polyphenol Whole Tumor Cell Vaccine in Patients With Advanced Malignant Solid Tumors". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT06878612. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*